Bilateral subthalamic nucleus stimulation does not improve prolonged P300 latencies in Parkinson's disease
暂无分享,去创建一个
Wilfried Lang | Bastiaan R. Bloem | Ross Cunnington | Lüder Deecke | Willibald Gerschlager | François Alesch | L. Deecke | W. Lang | B. Bloem | R. Cunnington | F. Alesch | W. Gerschlager
[1] E. John,et al. Evoked-Potential Correlates of Stimulus Uncertainty , 1965, Science.
[2] Y. Kuroiwa,et al. Visual event-related potentials in progressive supranuclear palsy, corticobasal degeneration, striatonigral degeneration, and Parkinson's disease , 2000, Journal of Neurology.
[3] F E Bloom,et al. P300 latency reflects the degree of cognitive decline in dementing illness. , 1986, Electroencephalography and clinical neurophysiology.
[4] Y. Kuroiwa,et al. Effect of interstimulus interval on visual P300 in Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.
[5] H Bauer,et al. Technical requirements for high-quality scalp DC recordings. , 1989, Electroencephalography and clinical neurophysiology.
[6] T. Takasu,et al. Effects of intravenous L-dopa on P300 and regional cerebral blood flow in parkinsonism. , 1996, The International journal of neuroscience.
[7] P. Calabresi,et al. Dopamine modulates CA1 hippocampal neurons by elevating the threshold for spike generation: An in vitro study , 1984, Neuroscience.
[8] G. Bernardi,et al. Age and stage dependency of P300 latency alterations in non-demented Parkinson's disease patients without therapy. , 1998, Electroencephalography and clinical neurophysiology.
[9] K. Syndulko,et al. Cognition in Parkinson disease: An event‐related potential perspective , 1982, Annals of neurology.
[10] Event-related potentials in Parkinson's disease. , 1996, Electromyography and clinical neurophysiology.
[11] D S Goodin,et al. Electrophysiological differences between demented and nondemented patients with Parkinson's disease. , 1987, Annals of neurology.
[12] Michael J. Aminoff,et al. Electrophysiological dfierences between demented and nondemented patients with Parkinson's disease , 1987 .
[13] E Donchin,et al. A metric for thought: a comparison of P300 latency and reaction time. , 1981, Science.
[14] A. Lang,et al. Surgery for Parkinson disease: A critical evaluation of the state of the art. , 2000, Archives of neurology.
[15] A. Zwinderman,et al. Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease , 1996, Movement disorders : official journal of the Movement Disorder Society.
[16] R. Leiguarda,et al. Evoked potentials, reaction time and cognitive performance in on and off phases of Parkinson's disease. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[17] S. Fahn. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .
[18] P. Stanzione,et al. P300 variations in parkinsonian patients before and during dopaminergic monotherapy: a suggested dopamine component in P300. , 1991, Electroencephalography and clinical neurophysiology.
[19] P. Svasek,et al. PC-Supported 64-Channel DC-EEG Amplifier , 1991, MIE.
[20] J. Rohrbaugh,et al. Endogenous potentials generated in the human hippocampal formation and amygdala by infrequent events. , 1980, Science.
[21] J. Rothwell,et al. The impact of deep brain stimulation on executive function in Parkinson's disease. , 2000, Brain : a journal of neurology.
[22] A L Benabid,et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. , 1998, Brain : a journal of neurology.
[23] J. Polich. P300 clinical utility and control of variability. , 1998, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[24] A. Benabid,et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 1998, The New England journal of medicine.
[25] A L Benabid,et al. Neuropsychological changes between “off” and “on” STN or GPi stimulation in Parkinson’s disease , 2000, Neurology.
[26] Y. Agid,et al. Doescognitive impairment inParkinson's disease result fromnon-dopaminergic lesions? , 1989 .
[27] L. Brown,et al. Sensory and cognitive functions of the basal ganglia , 1997, Current Opinion in Neurobiology.
[28] R. Verleger,et al. Reduction of P3b in patients with temporo-parietal lesions. , 1994, Brain research. Cognitive brain research.
[29] G. Kim,et al. Dopaminergic influences on the P300 abnormality in Parkinson's disease , 1998, Journal of the Neurological Sciences.
[30] A. Tröster,et al. Cognitive Outcomes after Deep Brain Stimulation for Parkinson's Disease: A Review of Initial Studies and Recommendations for Future Research , 2000, Brain and Cognition.
[31] C. Marsden. The mysterious motor function of the basal ganglia , 1982, Neurology.
[32] A L Benabid,et al. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: A consecutive series of 62 patients , 1999, Annals of neurology.
[33] M R Nuwer,et al. IFCN recommended standards for long-latency auditory event-related potentials. Report of an IFCN committee. International Federation of Clinical Neurophysiology. , 1994, Electroencephalography and clinical neurophysiology.
[34] W Lang,et al. Bilateral subthalamic nucleus stimulation improves frontal cortex function in Parkinson's disease. An electrophysiological study of the contingent negative variation. , 1999, Brain : a journal of neurology.